Literature DB >> 18473823

Induction of nuclear receptors and drug resistance in the brain microvascular endothelial cells treated with antiepileptic drugs.

Laura Lombardo1, Rosalia Pellitteri, Michael Balazy, Venera Cardile.   

Abstract

Our work contributes to the understanding of the mechanisms of drug resistance in epilepsis. This study aimed to investigate i) the levels of expression of P-glycoprotein (P-gp), and multidrug resistance-associated proteins (MRP)1 and 2, ii) the activation of the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR), and iii) the relationship between increased P-gp and MRPs expression and PXR and CAR activation, in immortalized rat brain microvascular endothelial cell lines, GPNT and RBE4, following treatment with the antiepileptic drugs (AEDs), topiramate, phenobarbital, carbamazepine, tiagabine, levetiracetam, and phenytoin, using Western blotting and immunocytochemistry methods. Carbamazepine, phenobarbital and phenytoin induced the highest levels of P-gp and MPRs expression that was associated with increased activation of PXR and CAR receptors as compared to levetiracetam, tiagabine and topiramate. We conclude that P-gp and MRPs are differently overexpressed in GPNT and RBE4 by various AEDs and both PXR and CAR are involved in the drug-resistant epilepsy induced by carbamazepine, phenobarbital and phenytoin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473823     DOI: 10.2174/156720208784310196

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  17 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  A concentration addition model to assess activation of the pregnane X receptor (PXR) by pesticide mixtures found in the French diet.

Authors:  Georges de Sousa; Ahmad Nawaz; Jean-Pierre Cravedi; Roger Rahmani
Journal:  Toxicol Sci       Date:  2014-07-15       Impact factor: 4.849

3.  P-glycoprotein Expression and Pharmacoresistant Epilepsy: Cause or Consequence?

Authors:  Barry E Gidal
Journal:  Epilepsy Curr       Date:  2014-05       Impact factor: 7.500

Review 4.  Psychotropic drug-drug interactions involving P-glycoprotein.

Authors:  Yumiko Akamine; Norio Yasui-Furukori; Ichiro Ieiri; Tsukasa Uno
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

5.  Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.

Authors:  Xueqian Wang; Destiny B Sykes; David S Miller
Journal:  Mol Pharmacol       Date:  2010-06-14       Impact factor: 4.436

Review 6.  Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy.

Authors:  Hadas Han; Aniv Mann; Dana Ekstein; Sara Eyal
Journal:  AAPS J       Date:  2017-05-26       Impact factor: 4.009

Review 7.  Influence of efflux transporters on drug metabolism: theoretical approach for bioavailability and clearance prediction.

Authors:  Pietro Fagiolino; Marta Vázquez; Rosa Eiraldi; Cecilia Maldonado; Alejandro Scaramelli
Journal:  Clin Pharmacokinet       Date:  2011-02       Impact factor: 6.447

8.  Gefitinib-phenytoin interaction is not correlated with the C-erythromycin breath test in healthy male volunteers.

Authors:  Stephanie Chhun; Celine Verstuyft; Nathalie Rizzo-Padoin; Guy Simoneau; Laurent Becquemont; Ilana Peretti; Alan Swaisland; Robert Wortelboer; Jean Francois Bergmann; Stephane Mouly
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

9.  Marked differences in the effect of antiepileptic and cytostatic drugs on the functionality of P-glycoprotein in human and rat brain capillary endothelial cell lines.

Authors:  Dana Alms; Maren Fedrowitz; Kerstin Römermann; Andreas Noack; Wolfgang Löscher
Journal:  Pharm Res       Date:  2014-01-30       Impact factor: 4.200

Review 10.  Elucidating the 'Jekyll and Hyde' nature of PXR: the case for discovering antagonists or allosteric antagonists.

Authors:  Arunima Biswas; Sridhar Mani; Matthew R Redinbo; Matthew D Krasowski; Hao Li; Sean Ekins
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.